Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aminopterin in Refractory Acute Leukemia
NCT00003305Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jul 1997
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aminopterin in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), sponsored by Sanofi. Started Jul 1997; status: completed.
02
Drugs
aminopterin
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00003305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003305.